pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 789 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    NVK-029
    Presbyopia Vyluma Inc
  • Phase 1
    NVK-031
    Unspecified Ophthalmological Disorders Vyluma Inc
  • Phase 1
    NX-1607
    Adenocarcinoma Of The Gastroesophageal Junction$NRIX Nurix Therapeutics, Inc.
  • Phase 1
← prev
page 16 of 27
next →
131
Pain89
Neurology1
NXP-900
Cervical Cancer
$NVCT Nuvectis Pharma, Inc.
  • Phase 1
    Nezavist
    Alcohol Use Disorder (AUD) Lohocla Research Corp
  • Phase 1
    OCF-001
    Vulvovaginal Candidiasis Sano Chemicals Inc
  • Phase 1
    OCU-200
    Diabetic Macular Edema$OCGN Ocugen, Inc.
  • Phase 1
    OLANZAPINE
    OLANZAPINE
    1 INDICATIONS AND USAGE Olanzapine is an atypical antipsy…$RDY DR REDDYS LABORATORIES LTD
  • Phase 1
    OLX-07010
    Alzheimer's Disease Oligomerix inc
  • Phase 1
    OLX-301A
    Dry (Atrophic) Macular Degeneration Laboratoires Thea SA
  • Phase 1
    OMS-527
    Substance (Drug) Abuse$OMER OMEROS CORP
  • Phase 1
    ONO-2910
    Diabetic Neuropathy Ono Pharmaceutical Co Ltd
  • Phase 1
    OP-3136
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$OLMA Olema Pharmaceuticals, Inc.
  • Phase 1
    OPC-214870
    Epilepsy Otsuka Pharmaceutical Co Ltd
  • Phase 1
    OPL-009
    Hypertension Overseas Pharmaceuticals Ltd
  • Phase 1
    OPN-6602
    Refractory Multiple Myeloma Opna Bio SA
  • Phase 1
    OTOV-101
    Deafness Suzhou Otovia Therapeutics Co Ltd
  • Phase 1
    OTS-167
    Metastatic Breast Cancer OncoTherapy Science Inc
  • Phase 1
    OV-329
    Seizures$OVID Ovid Therapeutics Inc.
  • Phase 1
    Oncoquest
    Oncoquest
    Chronic Lymphocytic Leukemia (CLL) XEME BioPharma Inc
  • Phase 1
    P-01
    Pancreatic Cancer Hangzhou Neoantigen Therapeutics Co Ltd
  • Phase 1
    PA-001
    Coronavirus Disease 2019 (COVID-19) PeptiAID Inc
  • Phase 1
    PAS-004
    Plexiform Neurofibroma$KTTA Pasithea Therapeutics Corp.
  • Phase 1
    PBCAR-19B
    Diffuse Large B-Cell Lymphoma$DTIL PRECISION BIOSCIENCES INC
  • Phase 1
    PBXCT-02
    Bladder Cancer Celltrion Inc
  • Phase 1
    PCNAT-01
    Pancreatic Ductal Adenocarcinoma Anda Biopharmaceutical Development (Shenzhen) Co Ltd
  • Phase 1
    PF-07832837
    Atopic Dermatitis (Atopic Eczema)$PFE PFIZER INC
  • Phase 1
    PF-08046052
    Head And Neck Squamous Cell Carcinoma (HNSC)$PFE PFIZER INC
  • Phase 1
    PF-08052666
    Endometrial Cancer$PFE PFIZER INC
  • Phase 1
    PF614-MPAR
    Pain$ENSC Ensysce Biosciences, Inc.